Monocyte activation in HIV/HCV coinfection correlates with cognitive impairment.
Rempel H, Sun B, Calosing C, Abadjian L, Monto A, Pulliam L, PLoS ONEImpaired lymphocyte reactivity as measured by immune function testing in untransplanted patients with cirrhosis.
Yee RM, Lehil MS, Rongey C, Shen H, Cozen ML, Shen H, Monto A, Ryan JC, Clinical and Vaccine ImmunologyNonresponse to interferon- anpha based treatment for chronic hepatitis C infection is associated with increased hazard of cirrhosis.
Cozen ML, Ryan JC, Shen H, Lerrigo R, Yee RM, Sheen E, Wu R, Monto A, PLoS ONEIs IL28B genotype associated with more than one aspect of viral clearance?
Monto A, Ryan JC, HepatologyManaging hepatitis C infection in the VA health care system: a roundtable discussion.
Ross D, Beste L, Dieperink E, Downey K, Monto A, Smith, J, Federal Practitioner SupplementRetreatment with consensus interferon/ribavirin for hepatitis C following nonresponse or relapse to pegylated interferon and ribavirin: results from a national VA clin...
Yee HS, Currie SL, Tortorice K, Cozen M, Shen H, Chapman S, Cunningham F, Monto A, Digestive Diseases and SciencesProgression of biopsy-measured liver fibrosis in untreated patients with hepatitis C infection: Non-Markov multistate model analysis.
Bacchetti P, Boylan RD, Astemborski J, Shen H, Mehta S, Thomas D, Terrault N, Monto A, PLoS ONECost-effectiveness of hepatitis A vaccination for individuals with chronic hepatitis C.
Chapko MK, Yee HS, Monto A, Dominitz JA, VaccineMultidisciplinary perspectives on management of hepatocellular carcinoma: a roundtable discussion.
Monto A, Kohlwes J, Raval GG, Mehta P, El-Serag HB, Taddei T, Federal PractitionerA prospective study to examine persistent HCV reinfection in injection drug users who have previously cleared the virus.
Currie SL, Ryan JC, Tracy D, Wright TL, George S, McQuaid R, Kim M, Shen H, Monto A, Drug and Alcohol DependenceImplementation of a multidisciplinary team for hepatocellular cancer at a Veterans Affairs Medical Center improves survival.
Chang TT, Sawhney R, Monto A, Davoren JB, Kirkland JG, Stewart L, Corvera CU, HPBThe association of human immunodeficiency virus infection with spontaneous hepatitis C virus resolution and level of viremia among injection drug users.
Seal KH, Monto A, Dove L, Shen H, Vittinghoff E, Tracy D, Miller E, Lau E, Wright TLIdentification of two gene variants associated with risk of advanced fibrosis in patients with chronic hepatitis C.
Huang H, Shiffman ML, Cheung RC, Layden TJ, Friedman S, Obar OT, Yee L, Chokkalingam AP, Schrodi SJ, Chan J, Catanese JJ, Leong DU, Ross D, Hu X, Monto A, McAllister LB, GastroenterologyHepatic steatosis in HIV- hepatitis C coinfection: prevalence and significance compared to hepatitis C monoinfection.
Monto A, Dove LM, Bostrom A, Kakar S, Tien P, Wright TL, HepatologyRisks of a range of alcohol intake on hepatitis C-related fibrosis.
Monto A, Patel K, Bostrom A, Pianko S, Pockros P, McHutchison JG, Wright TL, HepatologyOutcomes of interferon alpha and ribavirin treatment for chronic hepatitis C in patients with normal serum aminotransferases.
Hui CK, Monto A, Belaye T, Lau E, Wright TL, GutImplications for disease progression and treatment.
Monto A. Alcohol and Hepatitis C, Current Hepatitis ReportsRecent perspectives on hepatitis C and human immunodeficiency virus coinfection.
Monto A, Wright TL, Hepatitis Index & ReviewsSteatosis in chronic hepatitis C: relative contributions of obesity, diabetes mellitus, and alcohol.
Monto A, Alonzo J, Watson JJ, Grunfeld C, Wright TL, HepatologyHepatitis C and steatosis.
Monto A, Seminars in Gastrointestinal DiseaseThe epidemiology and prevention of hepatocellular carcinoma.
Monto A, Wright TL, Seminars in Oncology- Join now to see all